Superworth

Matinas BioPharma market cap MTNB

Share price times shares outstanding: what the whole company sells for, since 2014.

Today, Nov 2, 2026
$1.3M
Highest close in our data
$361.3M
Jan 2020

Matinas BioPharma is worth $1.3M at the close on Nov 2, 2026, at $1.29 a share.

That is down 81% over the last year and down 99% over five years.

Its highest close in our data was $361.3M in Jan 2020.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$1.3M$1.3M$5.2M−68%
2025$4M$2.7M$12M+51%
2024$2.6M$2.6M$65.2M−94%
2023$47M$28.2M$132.7M−57%
2022$108.4M$108.4M$204.6M−50%
2021$218.4M$143.9M$326.8M−19%
2020$271M$105.5M$361.3M−16%
2019$322.2M$67.3M$322.2M+370%
2018$68.6M$33.9M$118M−36%
2017$107.8M$81.8M$274.2M+33%
2016$81.3M$25.5M$112.3M+67%
2015$48.6M$11M$80.8M+236%
2014$14.5M$12.2M$30.4Mn/a

Against its peers

Companies in Drug Manufacturers - General nearest Matinas BioPharma's size, closest first, today.

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Matinas BioPharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.